Skip to main content
KARD
NASDAQ Life Sciences

Kardigan Shares Soar 38% on Nasdaq Debut After $400M Upsized IPO

Tom Rudovsky · Reported by Binance News
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$22
Mkt Cap
0
52W Low
0
52W High
0
52W Position
Off High
Rel. Volume
Market data snapshot near publication time

Summary

Kardigan's stock surged 38% in its Nasdaq trading debut, following an upsized initial public offering that raised $400 million. This strong first-day performance significantly exceeds earlier reports of a modest gain. The heart-health biotech priced 25 million shares at $16.00 each, indicating robust investor demand for the new issue.

At the time of this announcement, KARD was trading at $22.00 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Binance News.


Price Chart

Share this article

Copied!

KARD - Latest Insights

KARD
Aug 11, 2026, 7:10 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $14.79 info
Change: -$5.62 (-28%) info
Market Cap: $1.383B info
KARD
Aug 11, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $14.79 info
Change: -$5.62 (-28%) info
Market Cap: $1.383B info
KARD
Aug 11, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $14.79 info
Change: -$5.62 (-28%) info
Market Cap: $1.383B info
KARD
Jun 29, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $25.90
Real-time Price: $14.79 info
Change: -$11.11 (-43%) info
Market Cap: $1.383B info
KARD
Jun 25, 2026, 4:00 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $22.58
Real-time Price: $14.79 info
Change: -$7.79 (-34%) info
Market Cap: $1.383B info